Sign In
Buy TRNS
Transcat Earnings Calls
| Release date | Nov 03, 2025 |
| EPS estimate | $0.460 |
| EPS actual | $0.440 |
| EPS Surprise | -4.35% |
| Revenue estimate | 80.048M |
| Revenue actual | 82.272M |
| Revenue Surprise | 2.78% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.400 |
| EPS actual | $0.590 |
| EPS Surprise | 47.50% |
| Revenue estimate | 74.556M |
| Revenue actual | 76.424M |
| Revenue Surprise | 2.51% |
| Release date | May 19, 2025 |
| EPS estimate | $0.660 |
| EPS actual | $0.640 |
| EPS Surprise | -3.03% |
| Revenue estimate | 76.397M |
| Revenue actual | 77.134M |
| Revenue Surprise | 0.96% |
| Release date | Jan 27, 2025 |
| EPS estimate | $0.380 |
| EPS actual | $0.450 |
| EPS Surprise | 18.42% |
| Revenue estimate | 76.397M |
| Revenue actual | 66.754M |
| Revenue Surprise | -12.62% |
Last 4 Quarters for Transcat
Below you can see how TRNS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jan 27, 2025 |
| Price on release | $99.13 |
| EPS estimate | $0.380 |
| EPS actual | $0.450 |
| EPS surprise | 18.42% |
| Date | Price |
|---|---|
| Jan 21, 2025 | $104.58 |
| Jan 22, 2025 | $103.65 |
| Jan 23, 2025 | $102.03 |
| Jan 24, 2025 | $99.50 |
| Jan 27, 2025 | $99.13 |
| Jan 28, 2025 | $86.53 |
| Jan 29, 2025 | $73.50 |
| Jan 30, 2025 | $76.71 |
| Jan 31, 2025 | $77.02 |
| 4 days before | -5.21% |
| 4 days after | -22.30% |
| On release day | -12.71% |
| Change in period | -26.35% |
| Release date | May 19, 2025 |
| Price on release | $81.18 |
| EPS estimate | $0.660 |
| EPS actual | $0.640 |
| EPS surprise | -3.03% |
| Date | Price |
|---|---|
| May 13, 2025 | $81.43 |
| May 14, 2025 | $79.29 |
| May 15, 2025 | $80.89 |
| May 16, 2025 | $81.25 |
| May 19, 2025 | $81.18 |
| May 20, 2025 | $94.36 |
| May 21, 2025 | $90.39 |
| May 22, 2025 | $91.63 |
| May 23, 2025 | $91.32 |
| 4 days before | -0.307% |
| 4 days after | 12.49% |
| On release day | 16.24% |
| Change in period | 12.15% |
| Release date | Aug 06, 2025 |
| Price on release | $77.92 |
| EPS estimate | $0.400 |
| EPS actual | $0.590 |
| EPS surprise | 47.50% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $76.43 |
| Aug 01, 2025 | $74.55 |
| Aug 04, 2025 | $74.80 |
| Aug 05, 2025 | $75.64 |
| Aug 06, 2025 | $77.92 |
| Aug 07, 2025 | $80.01 |
| Aug 08, 2025 | $79.18 |
| Aug 11, 2025 | $79.38 |
| Aug 12, 2025 | $83.04 |
| 4 days before | 1.95% |
| 4 days after | 6.57% |
| On release day | 2.68% |
| Change in period | 8.65% |
| Release date | Nov 03, 2025 |
| Price on release | $70.62 |
| EPS estimate | $0.460 |
| EPS actual | $0.440 |
| EPS surprise | -4.35% |
| Date | Price |
|---|---|
| Oct 28, 2025 | $76.76 |
| Oct 29, 2025 | $74.27 |
| Oct 30, 2025 | $73.88 |
| Oct 31, 2025 | $72.65 |
| Nov 03, 2025 | $70.62 |
| Nov 04, 2025 | $62.35 |
| Nov 05, 2025 | $60.97 |
| Nov 06, 2025 | $58.02 |
| Nov 07, 2025 | $55.35 |
| 4 days before | -8.00% |
| 4 days after | -21.62% |
| On release day | -11.71% |
| Change in period | -27.89% |
Transcat Earnings Call Transcript Summary of Q3 2025
Transcat reported Q3 FY2025 consolidated revenue of $66.8M (up 2% YoY) while organic service revenue declined ~4%. The company attributed the quarter's service softness largely to an unexpected extended midweek December holiday that delayed calibrations and rentals (demand rebounded in January). Distribution revenue grew 7% (driven by product sales and rentals), but distribution margins were pressured by mix shifts caused by lower rental volume in December. Consolidated gross profit and adjusted EBITDA fell (gross profit down; adjusted EBITDA $7.9M, down 13% YoY). GAAP net income was $2.4M (EPS $0.25); adjusted diluted EPS was $0.45. Transcat completed the strategic acquisition of Martin Calibration on Dec 10 for $79M (cash + stock), expanding presence in the Midwest and adding complementary mechanical/dimensional capabilities to Transcat's temperature/pressure/electrical strengths. The balance sheet remains healthy (net debt $40.8M, leverage ~0.97x, ~$39.5M available on the credit facility). Management lowered near-term guidance to be conservative (expects FY2025 organic service growth in the low- to mid-single-digits when adjusted for a prior 53rd week), but emphasized a strong pipeline, belief that solutions performance will improve in FY2026, and confidence in returning to historical organic growth levels over time.
